Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

232.10

Today's Change

+12.04 (5.47%)

Day's Change

218.90 - 232.39

Trading Volume

304,451

Overview

Market Cap

4 Billion

Shares Outstanding

21 Million

Avg Volume

520,100

Avg Price (50 Days)

234.20

Avg Price (200 Days)

201.76

PE Ratio

-10.03

EPS

-23.15

Earnings Announcement

06-Aug-2024

Previous Close

220.06

Open

221.69

Day's Range

218.9 - 232.39

Year Range

119.76 - 302.68

Trading Volume

304,451

Price Change Highlight

1 Day Change

5.47%

5 Day Change

6.73%

1 Month Change

9.46%

3 Month Change

1.04%

6 Month Change

22.13%

Ytd Change

2.31%

1 Year Change

-18.70%

3 Year Change

78.85%

5 Year Change

132.61%

10 Year Change

59.41%

Max Change

-27.05%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment